Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2011 (2011), Article ID 530274, 10 pages
http://dx.doi.org/10.1155/2011/530274
Review Article

Cyclin-Dependent Kinase 5/p35/p39: A Novel and Imminent Therapeutic Target for Diabetes Mellitus

1Department of Pharmaceutical Sciences, Faculty of Health, Medical Sciences, Indigenous and Alternative Systems of Medicine, Sam Higginbottom Institute of Agriculture, Technology & Sciences (SHIATS), Allahabad 211007, India
2Department of Pharmacology, Faculty of Pharmacy, Jamia Hamdard, New Delhi 110062, India

Received 16 July 2011; Accepted 10 August 2011

Academic Editor: A. L. Barkan

Copyright © 2011 Danish Ahmed and Manju Sharma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Choi, A. S. Banks, J. L. Estall et al., “Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ 3 by Cdk5,” Nature, vol. 466, no. 7305, pp. 451–456, 2010. View at Publisher · View at Google Scholar · View at PubMed
  2. D. O. Morgan, “Cyclin-dependent kinases: engines, clocks, and microprocessors,” Annual Review of Cell and Developmental Biology, vol. 13, pp. 261–291, 1997. View at Publisher · View at Google Scholar · View at PubMed
  3. J. Lew, Q. Q. Huang, Z. Qi et al., “A brain-specific activator of cyclin-dependent kinase 5,” Nature, vol. 371, no. 6496, pp. 423–426, 1994. View at Publisher · View at Google Scholar · View at PubMed
  4. L. H. Tsai, I. Delalle, V. S. Caviness, T. Chae, and E. Harlow, “p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5,” Nature, vol. 371, no. 6496, pp. 419–423, 1994. View at Publisher · View at Google Scholar · View at PubMed
  5. D. Tang, J. Yeung, K. Y. Lee et al., “An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator,” Journal of Biological Chemistry, vol. 270, no. 45, pp. 26897–26903, 1995. View at Publisher · View at Google Scholar
  6. L. H. Tsai, T. Takahashi, V. S. Caviness, and E. Harlow, “Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system,” Development, vol. 119, no. 4, pp. 1029–1040, 1993. View at Google Scholar
  7. M. Ubeda, D. M. Kemp, and J. F. Habener, “Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic β-cells,” Endocrinology, vol. 145, no. 6, pp. 3023–3031, 2004. View at Publisher · View at Google Scholar · View at PubMed
  8. L. Lilja, J. U. Johansson, J. Gromada et al., “Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca2+-dependent exocytosis,” Journal of Biological Chemistry, vol. 279, no. 28, pp. 29534–29541, 2004. View at Publisher · View at Google Scholar · View at PubMed
  9. F. Y. Wei, K. Nagashima, T. Ohshima et al., “Cdk5-dependent regulation of glucose-stimulated insulin secretion,” Nature Medicine, vol. 11, no. 10, pp. 1104–1108, 2005. View at Publisher · View at Google Scholar · View at PubMed
  10. N. Ozaki, T. Shibasaki, Y. Kashima et al., “cAMP-GEFII is a direct target of cAMP in regulated exocytosis,” Nature Cell Biology, vol. 2, no. 11, pp. 805–811, 2000. View at Publisher · View at Google Scholar · View at PubMed
  11. P. D. Jeffrey, A. A. Russo, K. Polyak et al., “Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex,” Nature, vol. 376, no. 6538, pp. 313–320, 1995. View at Google Scholar
  12. A. A. Russo, P. D. Jeffrey, and N. P. Pavletich, “Structural basis of cyclin-dependent kinase activation by phosphorylation,” Nature Structural Biology, vol. 3, no. 8, pp. 696–700, 1996. View at Publisher · View at Google Scholar
  13. L. R. Zukerberg, G. N. Patrick, M. Nikolic et al., “Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth,” Neuron, vol. 26, no. 3, pp. 633–646, 2000. View at Google Scholar
  14. I. Matsuura and J. H. Wang, “Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus,” Journal of Biological Chemistry, vol. 271, no. 10, pp. 5443–5450, 1996. View at Publisher · View at Google Scholar
  15. A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler, “β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes,” Diabetes, vol. 52, no. 1, pp. 102–110, 2003. View at Publisher · View at Google Scholar
  16. T. Gurlo, S. Ryazantsev, C. J. Huang et al., “Evidence for proteotoxicity in β cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway,” American Journal of Pathology, vol. 176, no. 2, pp. 861–869, 2010. View at Publisher · View at Google Scholar · View at PubMed
  17. M. Stefani, “Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world,” Biochimica et Biophysica Acta, vol. 1739, no. 1, pp. 5–25, 2004. View at Publisher · View at Google Scholar · View at PubMed
  18. A. Sharma, L. K. Olson, R. P. Robertson, and R. Stein, “The reduction of insulin gene transcription in HIT-T15 β cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression,” Molecular Endocrinology, vol. 9, no. 9, pp. 1127–1134, 1995. View at Google Scholar
  19. L. K. Olson, A. Sharma, M. Peshavaria et al., “Reduction of insulin gene transcription in HIT-T15 β cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9127–9131, 1995. View at Publisher · View at Google Scholar
  20. J. L. Leahy, H. E. Cooper, D. A. Deal, and G. C. Weir, “Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions,” Journal of Clinical Investigation, vol. 77, no. 3, pp. 908–915, 1986. View at Google Scholar
  21. D. Kawamori, Y. Kajimoto, H. Kaneto et al., “Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH2-terminal kinase,” Diabetes, vol. 52, no. 12, pp. 2896–2904, 2003. View at Publisher · View at Google Scholar
  22. M. Ubeda, J. M. Rukstalis, and J. F. Habener, “Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity,” Journal of Biological Chemistry, vol. 281, no. 39, pp. 28858–28864, 2006. View at Publisher · View at Google Scholar · View at PubMed
  23. K. Ishiguro, S. Kobayashi, A. Omori et al., “Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of CDK5 in bovine brain,” FEBS Letters, vol. 342, no. 2, pp. 203–208, 1994. View at Publisher · View at Google Scholar
  24. G. S. Stein, R. Baserga, A. Giordano, and D. T. Denhardt, The Molecular Basis of Cell Cycle and Growth Control, vol. 28, Wiley-Liss, New York, NY, USA, 1999.
  25. R. Dhavan and L. H. Tsai, “A decade of CDK5,” Nature Reviews Molecular Cell Biology, vol. 2, no. 10, pp. 749–759, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. Malumbres and M. Barbacid, “To cycle or not to cycle: a critical decision in cancer,” Nature Reviews Cancer, vol. 1, no. 3, pp. 222–231, 2001. View at Google Scholar · View at Scopus
  27. V. Lalioti, D. Pulido, and I. V. Sandoval, “Cdk5, the multifunctional surveyor,” Cell Cycle, vol. 9, no. 2, pp. 284–311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Okada, E. Yamada, T. Saito et al., “CDK5-dependent phosphorylation of the Rho family GTPase TC10α regulates insulin-stimulated GLUT4 translocation,” Journal of Biological Chemistry, vol. 283, no. 51, pp. 35455–35463, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. V. Lalioti, G. Muruais, A. Dinarina, J. van Damme, J. Vandekerckhove, and I. V. Sandoval, “The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 11, pp. 4249–4253, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus